Ginkgo Bioworks Holdings, Inc. (DNA) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Ginkgo Bioworks Holdings, Inc. (DNA) Bundle
Streamline your analysis and improve precision with our (DNA) DCF Calculator! Utilizing genuine data from Ginkgo Bioworks and customizable assumptions, this tool empowers you to forecast, analyze, and evaluate Ginkgo Bioworks Holdings, Inc. like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54.2 | 76.7 | 313.8 | 477.7 | 251.5 | 343.4 | 469.1 | 640.7 | 875.1 | 1,195.2 |
| Revenue Growth, % | 0 | 41.48 | 309.4 | 52.21 | -47.36 | 36.58 | 36.58 | 36.58 | 36.58 | 36.58 |
| EBITDA | -106.7 | -108.6 | -1,806.7 | -2,059.7 | -821.3 | -343.4 | -469.1 | -640.7 | -875.1 | -1,195.2 |
| EBITDA, % | -196.85 | -141.65 | -575.67 | -431.16 | -326.62 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 10.8 | 13.9 | 29.1 | 61.6 | 71.6 | 60.8 | 83.1 | 113.5 | 155.0 | 211.7 |
| Depreciation, % | 19.85 | 18.09 | 9.26 | 12.9 | 28.46 | 17.71 | 17.71 | 17.71 | 17.71 | 17.71 |
| EBIT | -117.4 | -122.4 | -1,835.7 | -2,121.3 | -892.8 | -343.4 | -469.1 | -640.7 | -875.1 | -1,195.2 |
| EBIT, % | -216.69 | -159.74 | -584.94 | -444.06 | -355.07 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 495.3 | 380.8 | 1,550.0 | 1,315.8 | 944.1 | 343.4 | 469.1 | 640.7 | 875.1 | 1,195.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7.7 | 21.9 | 149.9 | 82.5 | 31.7 | 82.7 | 112.9 | 154.3 | 210.7 | 287.8 |
| Account Receivables, % | 14.17 | 28.58 | 47.76 | 17.26 | 12.62 | 24.08 | 24.08 | 24.08 | 24.08 | 24.08 |
| Inventories | .0 | 2.7 | 3.4 | 4.4 | .0 | 3.8 | 5.2 | 7.1 | 9.8 | 13.3 |
| Inventories, % | 0 | 3.57 | 1.07 | 0.91353 | 0.01829353 | 1.11 | 1.11 | 1.11 | 1.11 | 1.11 |
| Accounts Payable | 2.4 | 13.9 | 8.2 | 10.5 | 9.3 | 21.4 | 29.2 | 39.9 | 54.5 | 74.4 |
| Accounts Payable, % | 4.5 | 18.12 | 2.61 | 2.19 | 3.71 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
| Capital Expenditure | -22.2 | -57.8 | -56.5 | -52.3 | -40.8 | -111.0 | -151.6 | -207.1 | -282.8 | -386.3 |
| Capital Expenditure, % | -41.01 | -75.43 | -18.01 | -10.94 | -16.23 | -32.32 | -32.32 | -32.32 | -32.32 | -32.32 |
| Tax Rate, % | 0.00795126 | 0.00795126 | 0.00795126 | 0.00795126 | 0.00795126 | 0.00795126 | 0.00795126 | 0.00795126 | 0.00795126 | 0.00795126 |
| EBITAT | -116.9 | -124.2 | -1,827.7 | -2,104.8 | -892.8 | -342.3 | -467.5 | -638.6 | -872.2 | -1,191.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -133.6 | -173.7 | -1,989.5 | -2,026.8 | -808.1 | -435.2 | -559.9 | -764.7 | -1,044.5 | -1,426.6 |
| WACC, % | 7.86 | 7.87 | 7.86 | 7.86 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3,242.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1,455 | |||||||||
| Terminal Value | -24,805 | |||||||||
| Present Terminal Value | -16,987 | |||||||||
| Enterprise Value | -20,229 | |||||||||
| Net Debt | -702 | |||||||||
| Equity Value | -19,527 | |||||||||
| Diluted Shares Outstanding, MM | 49 | |||||||||
| Equity Value Per Share | -401.70 |
What You Will Get
- Pre-Filled Financial Model: Ginkgo Bioworks’ actual data facilitates accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, margins, WACC, and other critical drivers.
- Instant Calculations: Automatic updates provide real-time results as you make adjustments.
- Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
- Customizable and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasts.
Key Features
- Pre-Loaded Data: Ginkgo Bioworks' historical financial statements and pre-filled forecasts.
- Fully Adjustable Inputs: Customize WACC, tax rates, revenue growth, and EBITDA margins.
- Instant Results: View Ginkgo Bioworks' intrinsic value recalculated in real time.
- Clear Visual Outputs: Dashboard charts showcase valuation results and essential metrics.
- Built for Accuracy: A professional tool designed for analysts, investors, and finance professionals.
How It Works
- Download: Obtain the pre-configured Excel file containing Ginkgo Bioworks' financial data.
- Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and instantly compare the results.
- Make Decisions: Leverage the valuation outcomes to inform your investment strategy.
Why Choose This Calculator for Ginkgo Bioworks Holdings, Inc. (DNA)?
- Designed for Innovators: A sophisticated tool tailored for biotech analysts, investors, and strategists.
- Comprehensive Data: Ginkgo's historical and projected financials preloaded for precise analysis.
- Flexible Scenario Analysis: Easily simulate various forecasts and assumptions to guide decision-making.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and other essential metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth navigation through the calculator.
Who Should Use This Product?
- Individual Investors: Gain insights for making informed decisions about buying or selling Ginkgo Bioworks Holdings, Inc. (DNA) stock.
- Financial Analysts: Enhance valuation processes with efficient financial models tailored for Ginkgo Bioworks Holdings, Inc. (DNA).
- Consultants: Provide expert valuation insights to clients with speed and precision regarding Ginkgo Bioworks Holdings, Inc. (DNA).
- Business Owners: Learn how biotech companies like Ginkgo Bioworks Holdings, Inc. (DNA) are valued to inform your own business strategy.
- Finance Students: Explore valuation methodologies using real-world data and case studies from Ginkgo Bioworks Holdings, Inc. (DNA).
What the Template Contains
- Historical Data: Includes Ginkgo Bioworks’ past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Ginkgo Bioworks’ intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Ginkgo Bioworks’ financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.